Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 4 min 40 sec ago

Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting

Fri, 05/27/2016 - 13:37
Company Plans to Submit NDA and MAA for Betrixaban in Second Half of 2016 Webcast with APEX Study Executive Committee Members Today at 11 a.m. ET MONTPELLIER, France, and SOUTH SAN FRANCISCO, Calif. , May 27, 2016 -- (Healthcare Sales & Marketing Net...
Biopharmaceuticals
Portola Pharmaceuticals, betrixaban, thrombosis

Aclaris Therapeutics Announces $20.0 Million Private Placement

Fri, 05/27/2016 - 13:28
MALVERN, Pa., May 27, 2016 -- (Healthcare Sales & Marketing Network) -- Aclaris Therapeutics, Inc. (ACRS), a clinical-stage specialty pharmaceutical company, announced today that it has entered into a stock purchase agreement with a group of institutional ...
Biopharmaceuticals, Dermatology, Venture Capital
Aclaris Therapeutics, JAK inhibitor

AbbVie's HUMIRA(R) (adalimumab) Receives CHMP Positive Opinion to Treat Certain Forms of Non-Infectious Uveitis, a Disease that Can Severely Impact Vision

Fri, 05/27/2016 - 13:20
If approved by the European Commission, HUMIRA would be the first biologic treatment option in the European Union for certain patients with non-infectious intermediate, posterior and panuveitis The opinion is based on results from two pivotal Phase 3 st...
Biopharmaceuticals, Ophthalmology, Regulatory
AbbVie, HUMIRA, adalimumab, uveitis

Acumed Launches New State-of-the-Art System for Ankle Fractures

Thu, 05/26/2016 - 20:55
The Acumed Ankle Plating System 3 is composed of seven plate families that span the lateral, medial, and posterior malleoli. PORTLAND, Ore., May 26, 2016 -- (Healthcare Sales & Marketing Network) -- The Acumed Ankle Plating System 3 and Small Fragment ...
Devices, Orthopaedic, Product Launch
Acumed, Ankle Plating System 3, ankle fracture

New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres for Treatment of Hepatocellular Carcinoma

Thu, 05/26/2016 - 15:30
TARE (Transarterial Radio-embolization) Using Yttrium-90 Glass Microspheres, Associated With Both Cost Savings and Overall Decreased Use of Hospital Resource WASHINGTON, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- BTG plc (BTG.L), an inte...
Devices, Oncology
BTG, TheraSphere, Yttrium-90, Microspheres, hepatocellular carcinoma

Dynatronics Strengthens Its Sales Management Team

Thu, 05/26/2016 - 13:41
COTTONWOOD HEIGHTS, Utah, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- Dynatronics Corporation (DYNT), a manufacturer and distributor of advanced-technology medical devices and rehabilitation equipment for the physical therapy, sports medicin...
Devices, Orthopaedic, Personnel
Dynatronics, physical therapy, rehabilitation equipment

TransMedics, Inc. Announces Closing of $51.2 Million Growth Financing to Transform Organ Transplant Therapy

Thu, 05/26/2016 - 13:36
ANDOVER, Mass., May 26, 2016 -- (Healthcare Sales & Marketing Network) -- TransMedics, Inc., a medical technology company dedicated to improving quality, assessing viability and increasing the utilization of donor organs for transplantation announces toda...
Devices, Venture Capital
TransMedics, Organ Care System

Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller

Thu, 05/26/2016 - 13:29
LAVAL, Quebec, May 26, 2016 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (VRX) (VRX) ("Valeant") today announced that Sam Eldessouky has been named Senior Vice President and Corporate Controller effect...
Biopharmaceuticals, Personnel
Valeant Pharmaceuticals International

Third Installation of Elekta’s High-Field MR-Guided Linear Accelerator Underway at University Medical Centre Utrecht

Thu, 05/26/2016 - 13:23
Reinforces commitment to research exploring how real-time clinical imaging coupled with precision radiotherapy can improve patient outcomes STOCKHOLM--(Healthcare Sales & Marketing Network)--Elekta (EKTA-B.ST) and Royal Philips (NYSE:PHG, AEX:PHIA) toda...
Devices, Oncology
Elekta, Royal Philips, MR-guided linear accelerator, MR-linac

HeartStitch(R) Announces New Director of Regulatory Affairs and Quality Assurance

Wed, 05/25/2016 - 17:19
Faye Dunn Brings Wide-Ranging Experience to HeartStitch(R) Management and Manufacturing FOUNTAIN VALLEY, CA--(Healthcare Sales & Marketing Network) - Following a detailed search among a field of highly qualified candidates, the HeartStitch® Board of...
Devices, Cardiology, Personnel
HeartStitch, NobleStitch, vascular suture, PFO

Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer

Wed, 05/25/2016 - 17:07
WESTFORD, Mass., May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO) today announced that Timothy W. Baker has notified the Company that he plans to retire to pursue philanthropic interests. Mr. Baker has served as Cynosure's P...
Devices, Personnel
Cynosure, SculpSure

Ceterix Announces Appointment of Edward Graubart as Vice President, Sales

Wed, 05/25/2016 - 13:56
Seasoned Executive Brings Wealth of Sales, Product Launch Experience MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally i...
Devices, Orthopaedic, Personnel
Ceterix Orthopaedics, NovoStitch Plus, meniscal tear

Inivata Boosts Executive Team With Appointment of Clive Morris as Chief Medical Officer

Wed, 05/25/2016 - 13:48
CAMBRIDGE, England, May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Inivata, a global clinical cancer genomics company employing the precision of circulating tumour DNA (ctDNA) analysis to improve personalised healthcare in oncology, today annou...
Diagnostics, Personnel
Inivata Limited, ctDNA analysis, ctDNA, cancer genomics

Elekta Wins Public Tender to Deliver Advanced Cancer Care Solutions to New Karolinska Solna (NKS)

Wed, 05/25/2016 - 13:43
STOCKHOLM--(Healthcare Sales & Marketing Network)--Stockholm County Council (Sweden), announced today that Elekta has been awarded the public tender to exclusively equip the Radiation Therapy Department of its new, flagship hospital, the New Karolinska Sol...
Devices, Oncology, Neurosurgery
Elekta, radiation therapy, radiosurgery, brachytherapy

Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients

Wed, 05/25/2016 - 13:35
New test standardizes CMV testing for both solid organ and hematopoietic stem cell transplant recipients PLEASANTON, Calif., May 25, 2016 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the United States ...
Diagnostics, FDA
Roche Group, cytomegalovirus

Cynosure Receives FDA Clearance to Market New PicoSure(R) Energy Delivery System for Tattoos and Pigmented Lesions

Tue, 05/24/2016 - 15:13
Shipments of New 1064 nm Wavelength to Begin in the Second Half of 2016 WESTFORD, Mass., May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Broadening its product platform for tattoo removal and skin revitalization, Cynosure, Inc. (CYNO) today a...
Devices, Dermatology, FDA
Cynosure, PicoSure, picosecond laser, tattoo

Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors

Tue, 05/24/2016 - 15:10
SAN DIEGO, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Amplyx Pharmaceuticals today announced the appointment of Paul C. Grint, M.D., to its Board of Directors. Dr. Grint, president and CEO, Regulus Therapeutics, joined Regulus in June 2014 ...
Biopharmaceuticals, Personnel
Amplyx Pharmaceuticals, Candida, Aspergillus

Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%

Tue, 05/24/2016 - 15:07
Potential Treatment for Patients with Facial Erythema (Redness) Associated with Rosacea Allergan Expects PDUFA Date in First Half 2017 DUBLIN, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN) today announced that the New ...
Biopharmaceuticals, Dermatology, FDA
Allergan, Oxymetazoline, rosacea

Centinel Spine(TM) Expands STALIF(R) Internationally

Tue, 05/24/2016 - 13:01
NEW YORK, May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Centinel Spine, Inc., (Centinel Spine), the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices, expands its MIDLINE II-Ti product family, a Ti-ACTIVE™ coated, N...
Devices, Orthopaedic, Neurosurgery
Centinel Spine, Interbody fusion device, MIDLINE II-Ti, spine surgery

Interventional Spine, Inc. announces FDA Clearance of Lordotic Opticage(TM)

Tue, 05/24/2016 - 12:52
IRVINE, Calif., May 24, 2016 -- (Healthcare Sales & Marketing Network) -- Interventional Spine, Inc. announced today FDA clearance of its 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device. This device joins the Interventional Spine...
Devices, Orthopaedic, Neurosurgery, FDA
Interventional Spine, Lordotic Opticage, Interbody Fusion Devices, spine surgery

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong